QPRC, One for your list..:-)
Yesterdag (friday):
1) Wall Street West on QPRC
2) www.analystgroup.com on QPRC
3) Stock 2 Watch on QPRC
Read it all...Target all around 0,20$ short term
===============================================================
Wall Street West on QPRC!!!!
wallstreetwest.com
14000 members, watch next week.
Quest Products Corporation (OTCBB: QPRC: .04)
We put out a stock alert on this one several weeks ago at rougly this price level. The stock ran to the .08 area, and then retreated. That run was based on rumor. Today's run is based on fact. We are looking for a short term run to the .10 to .20 area, possibly higher over the next several days. We promised we would continue to look for the next Struthers (ran from .03 to .59) Could QPRC be the one? Here is the story:
QPRC announced today that it has successfully completed development of its newest product -- adjustable polarized sunglasses -- which allow the wearer to change the color of the sunglass lenses, at any time, to a variety of colors without changing the lenses or altering the frame. The concept has been in research and development by Quest for more than two years. The
invention is protected by U.S. Patent No. 5,546,141. Quest has the
exclusive right to manufacture and sell sunglasses, ski-goggles, diving
masks and all other applications of the patented technology.
The primary business of QPRC during the past several years has been the distribution and sale of its PHASE OUT product which is designed to help cigarette smokers quit smoking by modifying the cigarette rather than the smoker. PHASE OUT appeals to those individuals who are afraid or unwilling to try the patch products or to ingest drugs as well as to those persons who feel that they must continue to smoke while they are weaned off of
cigarettes. The PHASE OUT product is now available for sale in more than 12,000 retail stores throughout the United States including such major chain stores as RITE-AID, ECKERD, GENOVESE, JEWEL FOOD, LUCKY and OSCO. The RITE-AID chain of 3800 stores is presently in the process of installing new display units for better placement and marketing of PHASE OUT.
Last time we put out our alert on QPRC, the sunglasses were only a rumor. This news confirms that the sunglasses are real. We are in. If the stock continues to run and holds up well we will install a profile on the front page of Wall Street West.
===============================================================
QPRC email from analystgroup.com,
analystgroup.com Initiates Coverage of QUEST PRODUCTS CORP (OTC BB: QPRC)
with a "Strong Buy" Recommendation.
Recent Price: $0.024 52-Week Range: $0.01-$0.0625 Market Capitalization:
$5.95 million Shares Outstanding: 175 million Public Float: 60 million
Restricted shares; 115 million Projected Revenues: $47.6 million Projected
EPS: $0.12 Insider Holding: 65.7% Short-term target price: $0.75-$1.00
Recommendation: Strong Buy
Business and Corporation Background:
The Company's (http://www.quest-products.com/) primary product, PHASEOUT,
is
a patented device developed to help a person quit smoking without the use
of
any drugs, chemicals or attachments. The device was designed to gradually
reduce the amounts of nicotine, tar and carbon monoxide consumed from
cigarette smoke.
During the last four years, the company has been concentrating its efforts
in two areas: (1) test marketing the product domestically through various
channels of distribution and (2) entering into international distribution
agreements utilizing television infomercials and commercials.
The PHASEOUT device is a simple, easy to use, mechanical, light-weight
instrument that allows the smoker to continue to smoke their preferred
brand
cigarettes and at the same time, gradually and sequentially reduce their
nicotine intake by over 80%. This weaning process is the same type of
detoxification methodology that has proved successful with many other
addictive substances. Once the smoker has been weaned, their chances to
quit
for good are greatly enhanced. PHASEOUT's weaning methodology has an
important additional psychological benefit for all smokers. It allows the
smoker to continue to smoke their preferred brand until they are ready to
quit. Of course, to achieve these results under normal smoking conditions,
smokers must avoid compensatory practices, such as smoking more cigarettes
and blocking the ventilation holes created by the PHASEOUT device. The
PHASEOUT system works without the use of any drugs, chemicals or
attachments. The average retail price to consumers is $19.95 plus shipping
and handling. The average wholesale price is approximately $10-$12. The
cost
for PhaseOut manufacturing is less than $5 for each unit of PhaseOut. The
company is currently having the product manufactured by a vendor in South
Korea. The product is distributed via both its e- commerce site at
phase-out.com and 12,000 retail chain stores across the nation,
including RITE AID, ECKERD, GENOVESE, MEIJER, OSCO, SAVON, LUCKY SALES,
LUCKY NORTH, ACME MARKETS, JEWEL FOOD, and BI-LO.
The Market
Cigarette smoking is the number one cause of preventable illness and death
in the United States. In excess of 450,000 deaths were directly attributed
to cigarette smoking last year. More than one of every six deaths in the
U.S. is caused by cigarette smoking. Of the country's total health care
budget, approximately 25% ($65 billion) is spent for smoking related
illness
and diseases. Smoking-related health problems include emphysema, cancer,
and
heart disease. Also, smoking cigarettes for as few as five years can have
a
permanent effect on the lungs, the heart, the eyes, the throat, the
urinary
tract, the digestive organs, the bones and joints, and the skin. This does
not include an additional $35 billion in lost productivity and higher
insurance costs. In the United States, there are currently reported to be
approximately 46 million smokers. According to a report, the number of
smokers is estimated to be over 350 million worldwide and the annual costs
for smoke-related illness and disease have been over $300 billion
worldwide.
Currently, no medical treatment to cure smoke-related illness and diseases
exists. Only way out for smokers is to quit smoking. Many studies prove
that
tobacco-related health effects decline substantially as time away from
smoking increases; some of the benefits begin within months after
quitting.
There are two major products in the market for smoke quitting. One is
nicotine patch and another is nicotine gum. PhaseOut has some major
advantages over nicotine patch and gum product. First, nicotine patch and
nicotine gum are not working for many heavy smokers. There are over 11.2
million heavy smokers who have tried the patch and the gum, and they're
still smoking. Use of the PhaseOut filter perforation device allows
smokers
to continue smoking their usual preferred brand of cigarettes while
reducing
their exposure to harmful nicotine, tar, carbon monoxide and over 100
additional chemicals. This could have beneficial health effects, and could
be particularly useful as a weaning method prior to smoking cessation.
Second, PhaseOut is much less expensive than nicotine patch or gum.
One-time
charge of $19.95 can last for several years while the use nicotine patch
or
gum costs at least $3,000 in order to have any apparent effects on
smokers.
Third, PhaseOut is 100% natural and has no side effects that nicotine
patch
and nicotine gum often have such as skin irritation, insomnia, dry mouth,
vomiting and nervousness. Severe nicotine overdose can result when patch
and
gum users also smoke. Severe overdose symptoms are tremor, respiratory
failure, low blood pressure, and some heart attacks have been linked to
nicotine overdose.
Summary
Technical analysis indicates that QPRC's shares temporarily peaked at
$0.0625 in the middle of May before the company released its PhaseOut and
its e-commerce site, as the its Relative Strength generated a bearish
overbought reading. Since then, its trading is best described as quietly
basing, which is not surprising because QPRC, this little rough diamond,
has
not got much attention in the investment community. QPRC is getting ready
for the next move now. Its Relative Strength remains oversold despite any
real decline. Its On Balance Volume implies its shares are under heavy
accumulation, adding to its positive technical picture. In the final
analysis, many indicators suggest its current consolidation will end and
its
next leg up will begin and show an upside breakout from an ascending
triangle that has been basing at a higher level for three months. That
alone
without any other data targets the stock at 30 cents with relative ease.
QPRC is in an ideal technical state for a further advance to new highs.
Management is looking to increase earnings in QPRC through release of
several new products in addition to PhaseOut, which would provide strong
growth potential for its shareholders and give the company recurring per
share earnings with substantial cash flow. Several news products are
completed and will be released very soon via its a new e-commerce site at
quest-products.com, which is scheduled to be launched in the
middle of August. One of these new products is patent-pending sunglasses
which change colors. Several major sunglass companies and sport companies
are interested in licensing the rights to use this new and exciting
technology. It can also be used in ski goggles or diving masks or just
about
anything else. Also, the company is negotiating with several major drug
chain retailers including Walgreen for distribution of PhaseOut across the
nation and major international distributors for distribution of its
PhaseOut
worldwide. Also, the company is negotiating with several major web portals
to promote its new products, as well as PhaseOut.
We believe the company is about to come out in a huge way. Given this
severely undervalued situation in an exploding multi-billion dollar field,
these major developments makes QPRC a super turnaround situation capable
of
being one of this year's biggest movers. QPRC may turn out to be one of
the
greatest turnaround stocks in 20th century and could be last opportunity
that we will be ever able to grab before next millennium. We view QPRC as
an
excellent growth company with exceptional potential for capital
appreciation
over both the immediate and longer term. As industry and investor
awareness
of QPRC increases, new products are released, and contracts are signed and
announced, QPRC's shares should move much higher in the coming weeks. We
project the company will achieve annual revenues of $47.5 million with EPS
at $0.12. Hence, the stock is rated strong buy with a short-term target
price at $0.75-$1.00.
===============================================================
QPRC on Stocks 2 Watch,
target 0.19$ short term...
members.aol.com
==============================================================
Do your DD,
Daytrader1 |
